$PWOD
PENNS WOODS BANCORP INC Stock $pwod

$pwod Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000071660521000020 Filed on May 10, 2021

Income Statement

Concept	2021 Q1	2020 Q4	2020 Q1
Revenue	$14.60M	$15.05M	$16.16M
YoY Change	-9.69%	-8.34%	-1.66%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$890.0K	$830.0K	$820.0K
YoY Change	8.54%	-25.23%	7.89%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$2.525M	$3.079M	$4.000M
YoY Change	-36.88%	-24.79%	6.5%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$4.218M	$4.817M	$3.738M
YoY Change	12.84%	48.95%	-21.44%
Income Tax	$771.0K	$911.0K	$661.0K
% Of Pretax Income	18.28%	18.91%	17.68%
Net Earnings	$3.441M	$3.906M	$3.073M
YoY Change	11.98%	37.68%	-22.08%
Net Earnings / Revenue	23.58%	25.96%	19.01%
Basic Earnings Per Share	$0.49	$0.56	$0.44
Diluted Earnings Per Share	$0.49	$0.56	$0.44
COMMON SHARES
Basic Shares Outstanding	7.055M shares	7.052M shares	7.041M shares
Diluted Shares Outstanding	7.055M shares		7.103M shares

Balance Sheet

Concept	2021 Q1	2020 Q4	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$277.7M	$213.4M	$77.76M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$34.91M	$32.70M	$33.17M
YoY Change	5.25%	-0.69%	-0.3%
Goodwill	$17.10M	$17.10M	$17.10M
YoY Change	0.0%	0.0%	0.0%
Intangibles	$618.0K	$671.0K	$836.0K
YoY Change	-26.08%	-25.28%	-23.37%
Long-Term Investments
YoY Change
Other Assets	$3.700M	$2.500M	$3.300M
YoY Change	12.12%	-24.24%	-21.43%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$1.896B	$1.835B	$1.689B
YoY Change	12.3%	10.17%	-0.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.000M	$1.100M	$1.600M
YoY Change	-37.5%	-35.29%	23.08%
Accrued Expenses	$3.100M	$3.200M	$3.300M
YoY Change	-6.06%	-23.81%	-21.43%
Deferred Revenue
YoY Change
Short-Term Debt	$6.650M	$5.244M	$17.74M
YoY Change	-62.52%	6.59%	-79.0%
Long-Term Debt Due	$200.0K	$300.0K	$5.600M
YoY Change	-96.43%
Total Short-Term Liabilities	$4.300M	$4.600M	$10.50M
YoY Change	-59.05%	-22.03%	90.91%
LONG-TERM LIABILITIES
Long-Term Debt	$7.900M	$5.200M	$0.00
YoY Change		-7.14%	-100.0%
Other Long-Term Liabilities	$15.90M	$13.00M	$10.60M
YoY Change	50.0%	-5.11%	-24.29%
Total Long-Term Liabilities	$23.80M	$18.20M	$10.60M
YoY Change	124.53%	-5.7%	-47.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.300M	$4.600M	$10.50M
Total Long-Term Liabilities	$23.80M	$18.20M	$10.60M
Total Liabilities	$1.732B	$1.670B	$1.532B
YoY Change	13.07%	10.6%	-1.65%
SHAREHOLDERS EQUITY
Retained Earnings	$83.95M	$82.77M	$77.40M
YoY Change	8.46%	8.08%	8.22%
Common Stock	$41.87M	$41.85M	$41.79M
YoY Change	0.21%	0.16%	0.05%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$12.12M	$12.12M	$12.12M
YoY Change	0.0%	0.0%	0.0%
Treasury Stock Shares	480.2K shares	480.2K shares	480.2K shares
Shareholders Equity	$164.1M	$164.1M	$156.6M
YoY Change
Total Liabilities & Shareholders Equity	$1.896B	$1.835B	$1.689B
YoY Change	12.3%	10.17%	-0.95%

Cashflow Statement

Concept	2021 Q1	2020 Q4	2020 Q1
OPERATING ACTIVITIES
Net Income	$3.441M	$3.906M	$3.073M
YoY Change	11.98%	37.68%	-22.08%
Depreciation, Depletion And Amortization	$890.0K	$830.0K	$820.0K
YoY Change	8.54%	-25.23%	7.89%
Cash From Operating Activities	$9.390M	$7.100M	$8.608M
YoY Change	9.08%	-512.79%	36.68%
INVESTING ACTIVITIES
Capital Expenditures	-$200.0K	$160.0K	-$1.550M
YoY Change	-87.1%	-117.58%	150.0%
Acquisitions
YoY Change
Other Investing Activities	$1.010M	-$10.79M	-$1.190M
YoY Change	-184.87%	-281.04%	-43.33%
Cash From Investing Activities	$814.0K	-$10.63M	-$2.736M
YoY Change	-129.75%	-310.5%	0.77%
FINANCING ACTIVITIES
Cash Dividend Paid	$2.262M		$2.253M
YoY Change	0.4%		2.18%
Common Stock Issuance & Retirement, Net	$101.0K		$20.00K
YoY Change	405.0%		-4.76%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$54.13M	-9.380M	$23.30M
YoY Change	132.3%	-22.35%	612.32%
NET CHANGE
Cash From Operating Activities	$9.390M	7.100M	$8.608M
Cash From Investing Activities	$814.0K	-10.63M	-$2.736M
Cash From Financing Activities	$54.13M	-9.380M	$23.30M
Net Change In Cash	$64.33M	-12.91M	$29.17M
YoY Change	120.52%	47.54%	325.62%
FREE CASH FLOW
Cash From Operating Activities	$9.390M	$7.100M	$8.608M
Capital Expenditures	-$200.0K	$160.0K	-$1.550M
Free Cash Flow	$9.590M	$6.940M	$10.16M
YoY Change	-5.59%	-956.79%	46.83%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q1	dei	Amendment Flag AmendmentFlag	false
CY2021Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000716605
CY2021Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2021Q1	dei	Document Type DocumentType	10-Q
CY2021Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2021Q1	dei	Entity File Number EntityFileNumber	0-17077
CY2021Q1	dei	Entity Registrant Name EntityRegistrantName	PENNS WOODS BANCORP INC
CY2021Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	PA
CY2021Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	300 Market Street, P.O. Box 967
CY2020Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	1344327000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	14202000	USD
CY2021Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	23-2226454
CY2021Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Williamsport
CY2021Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	PA
CY2021Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	17703-0967
CY2021Q1	dei	City Area Code CityAreaCode	570
CY2021Q1	dei	Local Phone Number LocalPhoneNumber	322-1111
CY2021Q1	dei	Security12b Title Security12bTitle	Common stock, $5.55 par value
CY2021Q1	dei	Trading Symbol TradingSymbol	PWOD
CY2021Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2021Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021Q1	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7060829	shares
CY2021Q1	us-gaap	Cash And Due From Banks CashAndDueFromBanks	28539000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	13803000	USD
CY2021Q1	us-gaap	Trading Securities Debt TradingSecuritiesDebt	44000	USD
CY2020Q4	us-gaap	Trading Securities Debt TradingSecuritiesDebt	40000	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	1265000	USD
CY2020Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	1288000	USD
CY2020Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	31821000	USD
CY2021Q1	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	249149000	USD
CY2020Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	181537000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	277688000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	213358000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	166895000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	162261000	USD
CY2021Q1	us-gaap	Federal Reserve Bank Stock FederalReserveBankStock	15032000	USD
CY2020Q4	us-gaap	Federal Reserve Bank Stock FederalReserveBankStock	15377000	USD
CY2021Q1	us-gaap	Loans Receivable Held For Sale Net Not Part Of Disposal Group LoansReceivableHeldForSaleNetNotPartOfDisposalGroup	2568000	USD
CY2020Q4	us-gaap	Loans Receivable Held For Sale Net Not Part Of Disposal Group LoansReceivableHeldForSaleNetNotPartOfDisposalGroup	5239000	USD
CY2021Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	1335899000	USD
CY2021Q1	us-gaap	Notes Receivable Net NotesReceivableNet	1321697000	USD
CY2020Q4	us-gaap	Notes Receivable Net NotesReceivableNet	1330524000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3088000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3136000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	34910000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	32702000	USD
CY2021Q1	us-gaap	Interest Receivable InterestReceivable	8583000	USD
CY2020Q4	us-gaap	Interest Receivable InterestReceivable	8394000	USD
CY2021Q1	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	33839000	USD
CY2020Q4	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	33638000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	17104000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	17104000	USD
CY2021Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	618000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	671000	USD
CY2021Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	3717000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2526000	USD
CY2021Q1	us-gaap	Other Assets OtherAssets	9144000	USD
CY2020Q4	us-gaap	Other Assets OtherAssets	8385000	USD
CY2021Q1	us-gaap	Assets Assets	1896192000	USD
CY2020Q4	us-gaap	Assets Assets	1834643000	USD
CY2021Q1	us-gaap	Interest Bearing Deposit Liabilities Domestic InterestBearingDepositLiabilitiesDomestic	1085448000	USD
CY2020Q4	us-gaap	Interest Bearing Deposit Liabilities Domestic InterestBearingDepositLiabilitiesDomestic	1045086000	USD
CY2021Q1	us-gaap	Noninterest Bearing Deposit Liabilities Domestic NoninterestBearingDepositLiabilitiesDomestic	478916000	USD
CY2020Q4	us-gaap	Noninterest Bearing Deposit Liabilities Domestic NoninterestBearingDepositLiabilitiesDomestic	449357000	USD
CY2021Q1	us-gaap	Deposits Domestic DepositsDomestic	1564364000	USD
CY2020Q4	us-gaap	Deposits Domestic DepositsDomestic	1494443000	USD
CY2021Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	6650000	USD
CY2020Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	5244000	USD
CY2021Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	141094000	USD
CY2020Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	153475000	USD
CY2021Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	988000	USD
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	1112000	USD
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	3130000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	3175000	USD
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7532576	shares
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7057017	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7052351	shares
CY2021Q1	us-gaap	Noninterest Income NoninterestIncome	2614000	USD
CY2021Q1	us-gaap	Other Liabilities OtherLiabilities	15903000	USD
CY2020Q4	us-gaap	Other Liabilities OtherLiabilities	13048000	USD
CY2021Q1	us-gaap	Liabilities Liabilities	1732129000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	1670497000	USD
CY2021Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	3000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	3000000	shares
CY2021Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	5.55
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	5.55
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	22500000	shares
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	22500000	shares
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7537242	shares
CY2020Q4	us-gaap	Minority Interest MinorityInterest	4000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	164063000	USD
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	41873000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	164142000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	41847000	USD
CY2021Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	52818000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	52523000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	83948000	USD
CY2021Q1	us-gaap	Minority Interest MinorityInterest	4000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	4714000	USD
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	5560000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	82769000	USD
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	3095000	USD
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	12115000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	164059000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	5596000	USD
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	480225	shares
CY2021Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	480225	shares
CY2021Q1	us-gaap	Treasury Stock Value TreasuryStockValue	12115000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	164146000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1896192000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1834643000	USD
CY2021Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	13345000	USD
CY2020Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	14657000	USD
CY2021Q1	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	819000	USD
CY2020Q1	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	1010000	USD
CY2021Q1	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	171000	USD
CY2020Q1	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	145000	USD
CY2021Q1	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	260000	USD
CY2020Q1	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	349000	USD
CY2021Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	14595000	USD
CY2020Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	16161000	USD
CY2021Q1	us-gaap	Interest Expense Deposits InterestExpenseDeposits	1684000	USD
CY2020Q1	us-gaap	Interest Expense Deposits InterestExpenseDeposits	3035000	USD
CY2021Q1	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	2000	USD
CY2020Q1	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	22000	USD
CY2021Q1	us-gaap	Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm	839000	USD
CY2020Q1	us-gaap	Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm	943000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	2525000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	4000000	USD
CY2021Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	12070000	USD
CY2021Q1	us-gaap	Debt Securities Trading Gain Loss DebtSecuritiesTradingGainLoss	4000	USD
CY2020Q1	us-gaap	Debt Securities Trading Gain Loss DebtSecuritiesTradingGainLoss	-14000	USD
CY2020Q1	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	455000	USD
CY2020Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	12161000	USD
CY2021Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	515000	USD
CY2020Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	750000	USD
CY2021Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	11555000	USD
CY2020Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	11411000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	138000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	21000	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-23000	USD
CY2020Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	20000	USD
CY2021Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	173000	USD
CY2020Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	192000	USD
CY2021Q1	us-gaap	Gain Loss On Sale Of Mortgage Loans GainLossOnSaleOfMortgageLoans	908000	USD
CY2020Q1	us-gaap	Gain Loss On Sale Of Mortgage Loans GainLossOnSaleOfMortgageLoans	444000	USD
CY2021Q1	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	275000	USD
CY2020Q1	us-gaap	Noninterest Income NoninterestIncome	2437000	USD
CY2021Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	5598000	USD
CY2020Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	5667000	USD
CY2021Q1	us-gaap	Occupancy Net OccupancyNet	976000	USD
CY2020Q1	us-gaap	Occupancy Net OccupancyNet	702000	USD
CY2021Q1	us-gaap	Equipment Expense EquipmentExpense	809000	USD
CY2020Q1	us-gaap	Equipment Expense EquipmentExpense	860000	USD
CY2021Q1	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	198000	USD
CY2020Q1	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	250000	USD
CY2021Q1	pwod	Share Tax Expense ShareTaxExpense	352000	USD
CY2020Q1	pwod	Share Tax Expense ShareTaxExpense	285000	USD
CY2021Q1	us-gaap	Professional Fees ProfessionalFees	583000	USD
CY2020Q1	us-gaap	Professional Fees ProfessionalFees	622000	USD
CY2021Q1	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	221000	USD
CY2020Q1	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	194000	USD
CY2021Q1	us-gaap	Marketing Expense MarketingExpense	63000	USD
CY2020Q1	us-gaap	Marketing Expense MarketingExpense	53000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	53000	USD
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	62000	USD
CY2021Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	1098000	USD
CY2020Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	1415000	USD
CY2021Q1	us-gaap	Noninterest Expense NoninterestExpense	9951000	USD
CY2020Q1	us-gaap	Noninterest Expense NoninterestExpense	10110000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	4218000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	3738000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	771000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	661000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	3447000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	3077000	USD
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	6000	USD
CY2020Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	4000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	3441000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	3073000	USD
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.49
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.44
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.49
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.43
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7055116	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7040740	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7055116	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7102990	shares
CY2021Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.32
CY2020Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.32
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	3441000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	3073000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-1911000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	694000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-401000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	146000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	138000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3637000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	21000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	29000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	4000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax	-46000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax	-41000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	-10000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	-8000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1583000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	564000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1858000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	164146000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	3447000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1583000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	220000	USD
CY2021Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.32
CY2021Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	2262000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	20000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	81000	USD
CY2021Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	6000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	164063000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	154982000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	3077000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	564000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	198000	USD
CY2020Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.32
CY2020Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	2253000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	20000	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	156588000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	3447000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	3077000	USD
CY2021Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	839000	USD
CY2020Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	760000	USD
CY2021Q1	us-gaap	Gain Loss On Sale Of Mortgage Loans GainLossOnSaleOfMortgageLoans	908000	USD
CY2021Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2020Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	14000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	53000	USD
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	62000	USD
CY2021Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	515000	USD
CY2020Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	750000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	220000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	198000	USD
CY2021Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-251000	USD
CY2020Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-171000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Gain Loss DebtSecuritiesAvailableForSaleGainLoss	138000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Gain Loss DebtSecuritiesAvailableForSaleGainLoss	21000	USD
CY2021Q1	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	26658000	USD
CY2020Q1	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	14977000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	30237000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	15359000	USD
CY2020Q1	us-gaap	Gain Loss On Sale Of Mortgage Loans GainLossOnSaleOfMortgageLoans	444000	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-23000	USD
CY2020Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	20000	USD
CY2021Q1	us-gaap	Debt Securities Trading Gain Loss DebtSecuritiesTradingGainLoss	4000	USD
CY2020Q1	us-gaap	Debt Securities Trading Gain Loss DebtSecuritiesTradingGainLoss	-14000	USD
CY2021Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	173000	USD
CY2020Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	192000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	761000	USD
CY2020Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	84000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Securities Operating Activities ProceedsFromSaleOfSecuritiesOperatingActivities	0	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Securities Operating Activities ProceedsFromSaleOfSecuritiesOperatingActivities	6627000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-2447000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	2658000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	9390000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	8608000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	11372000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	2774000	USD
CY2021Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	3428000	USD
CY2020Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	2598000	USD
CY2021Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	21955000	USD
CY2020Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	11753000	USD
CY2021Q1	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	-8312000	USD
CY2020Q1	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	-5861000	USD
CY2021Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	197000	USD
CY2020Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	1547000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	336000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Foreclosed Assets ProceedsFromSaleOfForeclosedAssets	246000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Foreclosed Assets ProceedsFromSaleOfForeclosedAssets	226000	USD
CY2021Q1	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	26000	USD
CY2020Q1	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	26000	USD
CY2021Q1	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	0	USD
CY2020Q1	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	248000	USD
CY2021Q1	us-gaap	Payments To Acquire Limited Partnership Interests PaymentsToAcquireLimitedPartnershipInterests	711000	USD
CY2020Q1	us-gaap	Payments To Acquire Limited Partnership Interests PaymentsToAcquireLimitedPartnershipInterests	370000	USD
CY2021Q1	pwod	Proceeds From Redemption Of Regulatory Stock ProceedsFromRedemptionOfRegulatoryStock	1082000	USD
CY2020Q1	pwod	Proceeds From Redemption Of Regulatory Stock ProceedsFromRedemptionOfRegulatoryStock	1139000	USD
CY2021Q1	pwod	Purchases Of Regulatory Stock PurchasesOfRegulatoryStock	737000	USD
CY2020Q1	pwod	Purchases Of Regulatory Stock PurchasesOfRegulatoryStock	2222000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	814000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2736000	USD
CY2021Q1	us-gaap	Net Change Interest Bearing Deposits Domestic NetChangeInterestBearingDepositsDomestic	40362000	USD
CY2020Q1	us-gaap	Net Change Interest Bearing Deposits Domestic NetChangeInterestBearingDepositsDomestic	4716000	USD
CY2021Q1	us-gaap	Net Change Noninterest Bearing Deposits Domestic NetChangeNoninterestBearingDepositsDomestic	29559000	USD
CY2020Q1	us-gaap	Net Change Noninterest Bearing Deposits Domestic NetChangeNoninterestBearingDepositsDomestic	-1987000	USD
CY2021Q1	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	0	USD
CY2020Q1	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	35000000	USD
CY2021Q1	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	15000000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	277688000	USD
CY2020Q1	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	25000000	USD
CY2021Q1	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	1406000	USD
CY2020Q1	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	12821000	USD
CY2021Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	34000	USD
CY2020Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	17000	USD
CY2021Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	2262000	USD
CY2020Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	2253000	USD
CY2021Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	6000	USD
CY2020Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	101000	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	20000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	54126000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	23300000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	64330000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	29172000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	213358000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	48589000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	77761000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	2649000	USD
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	4036000	USD
CY2021Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2020Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	2653000	USD
CY2020Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	USD
CY2021Q1	pwod	Transfer From Loans To Foreclosed Assets TransferFromLoansToForeclosedAssets	0	USD
CY2020Q1	pwod	Transfer From Loans To Foreclosed Assets TransferFromLoansToForeclosedAssets	139000	USD
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	841275	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	28.17
CY2021Q1	pwod	Share Price Average Price SharePriceAveragePrice	20.21
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	864300	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	29.20
CY2020Q1	pwod	Share Price Average Price SharePriceAveragePrice	29.57
CY2021Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	7535341	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	7520965	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Treasury Stock WeightedAverageNumberOfSharesTreasuryStock	480225	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Treasury Stock WeightedAverageNumberOfSharesTreasuryStock	480225	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7055116	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7040740	shares
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2020Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	62250	shares
CY2021Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	7055116	shares
CY2020Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	7102990	shares
CY2021Q1	pwod	Available For Sale Securities In Unrealized Loss Positions Number Of Positions Less Than Twelve Months AvailableForSaleSecuritiesInUnrealizedLossPositionsNumberOfPositionsLessThanTwelveMonths	62	security
CY2021Q1	pwod	Available For Sale Securities In Unrealized Loss Positions Number Of Positions Greater Than Twelve Months AvailableForSaleSecuritiesInUnrealizedLossPositionsNumberOfPositionsGreaterThanTwelveMonths	7	security
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	11176000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	11158000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	71403000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	72665000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	70964000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	73612000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	9434000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	9460000	USD
CY2021Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	162977000	USD
CY2021Q1	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	166895000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	11372000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	2774000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	138000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	21000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	0	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	0	USD
CY2020Q1	us-gaap	Other Than Temporary Impairment Loss Debt Securities Available For Sale OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale	0	USD
CY2021Q1	us-gaap	Other Than Temporary Impairment Loss Debt Securities Available For Sale OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale	0	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Restricted DebtSecuritiesAvailableForSaleRestricted	109699000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Restricted DebtSecuritiesAvailableForSaleRestricted	111247000	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	1265000	USD
CY2020Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	1288000	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-23000	USD
CY2020Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	20000	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	0	USD
CY2020Q1	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	0	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-23000	USD
CY2020Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	20000	USD
CY2021Q1	us-gaap	Debt Securities Trading Realized Gain Loss DebtSecuritiesTradingRealizedGainLoss	0	USD
CY2020Q1	us-gaap	Debt Securities Trading Realized Gain Loss DebtSecuritiesTradingRealizedGainLoss	0	USD
CY2021Q1	us-gaap	Debt Securities Trading Unrealized Gain Loss DebtSecuritiesTradingUnrealizedGainLoss	4000	USD
CY2020Q1	us-gaap	Debt Securities Trading Unrealized Gain Loss DebtSecuritiesTradingUnrealizedGainLoss	-14000	USD
CY2021Q1	us-gaap	Debt Securities Trading Gain Loss DebtSecuritiesTradingGainLoss	4000	USD
CY2020Q1	us-gaap	Debt Securities Trading Gain Loss DebtSecuritiesTradingGainLoss	-14000	USD
CY2021Q1	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	1322166000	USD
CY2021Q1	pwod	Financing Receivable Recorded Investment30 To89 Days Past Due FinancingReceivableRecordedInvestment30To89DaysPastDue	3981000	USD
CY2021Q1	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	607000	USD
CY2021Q1	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	8665000	USD
CY2021Q1	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	1335419000	USD
CY2021Q1	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	480000	USD
CY2021Q1	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	480000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	14202000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	14202000	USD
CY2021Q1	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	1308444000	USD
CY2021Q1	us-gaap	Notes Receivable Net NotesReceivableNet	1321697000	USD
CY2020Q4	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	1323782000	USD
CY2020Q4	pwod	Financing Receivable Recorded Investment30 To89 Days Past Due FinancingReceivableRecordedInvestment30To89DaysPastDue	9188000	USD
CY2020Q4	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	1212000	USD
CY2020Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	9122000	USD
CY2020Q4	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	1343304000	USD
CY2020Q4	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	1023000	USD
CY2020Q4	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	1023000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	13803000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	13803000	USD
CY2020Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	1311002000	USD
CY2020Q4	us-gaap	Notes Receivable Net NotesReceivableNet	1330524000	USD
CY2021Q1	pwod	Loans And Leases Receivable Interest Income If Recorded On Original Loan Basis For Non Accrual Loans LoansAndLeasesReceivableInterestIncomeIfRecordedOnOriginalLoanBasisForNonAccrualLoans	68000	USD
CY2021Q1	pwod	Loans And Leases Receivable Interest On Non Accrual Loans LoansAndLeasesReceivableInterestOnNonAccrualLoans	0	USD
CY2020Q1	pwod	Loans And Leases Receivable Interest Income If Recorded On Original Loan Basis For Non Accrual Loans LoansAndLeasesReceivableInterestIncomeIfRecordedOnOriginalLoanBasisForNonAccrualLoans	62000	USD
CY2020Q1	pwod	Loans And Leases Receivable Interest On Non Accrual Loans LoansAndLeasesReceivableInterestOnNonAccrualLoans	0	USD
CY2021Q1	pwod	Financing Receivable Individually Evaluated For Impairment Minimum Amount FinancingReceivableIndividuallyEvaluatedForImpairmentMinimumAmount	100000	USD
CY2021Q1	pwod	Financing Receivable Individually Evaluated For Impairment On Case By Case Basis Maximum Amount FinancingReceivableIndividuallyEvaluatedForImpairmentOnCaseByCaseBasisMaximumAmount	100000	USD
CY2021Q1	pwod	Payment Delays Limit Up To Which Loans Not Classified As Impaired Maximum PaymentDelaysLimitUpToWhichLoansNotClassifiedAsImpairedMaximum	P90D
CY2021Q1	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	11435000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	14222000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	7653000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	7653000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	2043000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	19088000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	21875000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	2043000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	12366000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	15153000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	4317000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	4317000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	1035000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	16683000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	19470000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	1035000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	16310000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	79000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable Interest Income Cash Basis Method ImpairedFinancingReceivableInterestIncomeCashBasisMethod	0	USD
CY2020Q1	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	16825000	USD
CY2020Q1	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	84000	USD
CY2020Q1	us-gaap	Impaired Financing Receivable Interest Income Cash Basis Method ImpairedFinancingReceivableInterestIncomeCashBasisMethod	0	USD
CY2021Q1	pwod	Reasonable Period To Classify From Troubled Debt Restructuring Non Performing Loans To Performing Loans ReasonablePeriodToClassifyFromTroubledDebtRestructuringNonPerformingLoansToPerformingLoans	P6M
CY2021Q1	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	2	contract
CY2020Q1	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	0	contract
CY2021Q1	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	2	contract
CY2021Q1	us-gaap	Financing Receivable Modifications Pre Modification Recorded Investment2 FinancingReceivableModificationsPreModificationRecordedInvestment2	812000	USD
CY2021Q1	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2	812000	USD
CY2021Q1	us-gaap	Financing Receivable Modifications Subsequent Default Number Of Contracts1 FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1	1	contract
CY2020Q1	us-gaap	Financing Receivable Modifications Subsequent Default Number Of Contracts1 FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1	3	contract
CY2021Q1	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	13294000	USD
CY2020Q4	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	12359000	USD
CY2021Q1	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	68000	USD
CY2020Q4	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	401000	USD
CY2021Q1	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	421000	USD
CY2020Q4	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	629154	USD
CY2021Q1	pwod	Number Of Categories Considered Not Criticized And Rated NumberOfCategoriesConsideredNotCriticizedAndRated	6	category
CY2021Q1	pwod	Period Financing Receivables Past Due After Which Loans Are Considered Substandard Minimum PeriodFinancingReceivablesPastDueAfterWhichLoansAreConsideredSubstandardMinimum	P90D
CY2021Q1	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	1335419000	USD
CY2020Q4	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	1343304000	USD
CY2021Q1	pwod	Number Of Components Represent Allowance For Loan Losses NumberOfComponentsRepresentAllowanceForLoanLosses	2	component
CY2021Q1	pwod	Number Of Classes That Groups Loans Are Collectively Evaluated For Impairment NumberOfClassesThatGroupsLoansAreCollectivelyEvaluatedForImpairment	2	class
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	13803000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	174000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	58000	USD
CY2021Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	515000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	14202000	USD
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	11894000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	230000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	86000	USD
CY2020Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	750000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	12500000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	2043000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	12159000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	14202000	USD
CY2021Q1	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	19088000	USD
CY2021Q1	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	1316331000	USD
CY2021Q1	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	1335419000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	1035000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	12768000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	13803000	USD
CY2020Q4	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	16683000	USD
CY2020Q4	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	1326621000	USD
CY2020Q4	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	1343304000	USD
CY2021Q1	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	127000	USD
CY2020Q1	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	160000	USD
CY2021Q1	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	386000	USD
CY2020Q1	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	318000	USD
CY2021Q1	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	-46000	USD
CY2020Q1	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	-41000	USD
CY2021Q1	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	-213000	USD
CY2020Q1	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	-117000	USD
CY2020Q4	us-gaap	Defined Benefit Plan Expected Future Employer Contributions Next Fiscal Year DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear	500000	USD
CY2021Q1	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	200000	USD
CY2021Q1	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Remainder Of Fiscal Year DefinedBenefitPlanExpectedFutureBenefitPaymentsRemainderOfFiscalYear	300000	USD
CY2021Q1	us-gaap	Fair Value Disclosure Offbalance Sheet Risks Face Amount Liability FairValueDisclosureOffbalanceSheetRisksFaceAmountLiability	236056000	USD
CY2020Q4	us-gaap	Fair Value Disclosure Offbalance Sheet Risks Face Amount Liability FairValueDisclosureOffbalanceSheetRisksFaceAmountLiability	217814000	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	841275	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	58125	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	24000	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	34125	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	28.02
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P5Y
CY2015Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	841275	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	28.17
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	625800	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	29.29
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	238500	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	25.34
CY2021Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2020Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	841275	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	28.17
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	864300	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	29.20
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	113250	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	29.13
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	62625	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	29.47
CY2021Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	7758000	USD
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	5257000	USD
CY2021Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	8094000	USD
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	5475000	USD
CY2021Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	152000	USD
CY2020Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	50000	USD
CY2021Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	71000	USD
CY2020Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	53000	USD
CY2021Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	76000	USD
CY2020Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	91000	USD
CY2021Q1	us-gaap	Variable Lease Cost VariableLeaseCost	0	USD
CY2020Q1	us-gaap	Variable Lease Cost VariableLeaseCost	0	USD
CY2021Q1	us-gaap	Lease Cost LeaseCost	299000	USD
CY2020Q1	us-gaap	Lease Cost LeaseCost	194000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	219000	USD
CY2021Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	314000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	298000	USD
CY2021Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	419000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	273000	USD
CY2021Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	421000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	262000	USD
CY2021Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	427000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	265000	USD
CY2021Q1	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	929000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	2911000	USD
CY2021Q1	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	9664000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4228000	USD
CY2021Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	12174000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1098000	USD
CY2021Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	4080000	USD
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	3130000	USD
CY2021Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	8094000	USD
CY2021Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P18Y1M6D
CY2021Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P25Y1M6D
CY2021Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0351
CY2021Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0319
CY2021Q1	pwod	Reclassification Adjustment Effect On Net Income Loss ReclassificationAdjustmentEffectOnNetIncomeLoss	0	USD
CY2021Q1	pwod	Risks And Uncertainties RisksAndUncertainties	Risks and Uncertainties The impact of COVID-19 on the Corporation’s financial results is evolving and uncertain. The pandemic and its associated impacts on trade, travel, employee productivity, unemployment and consumer spending has resulted in less economic activity and volatility and disruption in the financial markets. The ultimate extent of the impact of the COVID-19 pandemic on the Company 's business, financial condition, and results of operations is currently uncertain and will depend on various developments and other factors, including, among others, the duration and scope of the pandemic, as well as governmental, regulatory, and private sector responses to the pandemic, and the associated impacts on the economy, financial markets and our customers, employees, and vendors. While the full effects of the pandemic remain unknown, the Company is committed to supporting its customers, employees, and communities during this difficult time.

Files In Submission

Name	View Source	Status
0000716605-21-000020-index-headers.html	Edgar Link	pending
0000716605-21-000020-index.html	Edgar Link	pending
0000716605-21-000020.txt	Edgar Link	pending
0000716605-21-000020-xbrl.zip	Edgar Link	pending
ex311-1q21.htm	Edgar Link	pending
ex312-1q21.htm	Edgar Link	pending
ex321-1q21.htm	Edgar Link	pending
ex322-1q21.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pwod-20210331.htm	Edgar Link	pending
pwod-20210331.xsd	Edgar Link	pending
pwod-20210331_cal.xml	Edgar Link	unprocessable
pwod-20210331_def.xml	Edgar Link	unprocessable
pwod-20210331_htm.xml	Edgar Link	completed
pwod-20210331_lab.xml	Edgar Link	unprocessable
pwod-20210331_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PWOD
PENNS WOODS BANCORP INC Stock $pwod

2021 Q1 Form 10-Q Financial Statement

#000071660521000020 Filed on May 10, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PWOD PENNS WOODS BANCORP INC Stock $pwod

2021 Q1 Form 10-Q Financial Statement

#000071660521000020 Filed on May 10, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PWOD
PENNS WOODS BANCORP INC Stock $pwod